In this section
@article{Akbari:2025:10.1007/s11886-025-02241-8,
author = {Akbari, T and Hammersley, DJ and May, CY-Y and Halliday, BP and Prasad, SK},
doi = {10.1007/s11886-025-02241-8},
journal = {Current Cardiology Reports},
title = {The impact of cardio-renal-metabolic profile in dilated cardiomyopathy},
url = {http://dx.doi.org/10.1007/s11886-025-02241-8},
volume = {27},
year = {2025}
}
TY - JOUR
AB - Purpose of ReviewDilated cardiomyopathy is an important contributor to heart failure burden worldwide. With an aging population and rising multimorbidity, in this review, we describe the prevalence of metabolic syndrome and renal failure in patients with dilated cardiomyopathy and focus on common underlying mechanisms, evaluate outcomes in these patients and highlight newer therapeutic strategies.Recent FindingsA significant proportion of patients with dilated cardiomyopathy has concomitant metabolic syndrome and renal disease. This combination of multimorbidity portends worse prognosis and often presents unique challenges in treatment given the complex interplay and shared pathophysiological pathways.SummaryOptimization of the cardio-renal-metabolic profile should be a key consideration in the management of patients with dilated cardiomyopathy. Therapeutic strategies targeting common pathophysiological pathways are needed in order to improve overall outcomes.
AU - Akbari,T
AU - Hammersley,DJ
AU - May,CY-Y
AU - Halliday,BP
AU - Prasad,SK
DO - 10.1007/s11886-025-02241-8
PY - 2025///
SN - 1534-3170
TI - The impact of cardio-renal-metabolic profile in dilated cardiomyopathy
T2 - Current Cardiology Reports
UR - http://dx.doi.org/10.1007/s11886-025-02241-8
UR - https://doi.org/10.1007/s11886-025-02241-8
VL - 27
ER -